Systematic review / meta-analysis / 2021
Low-carbohydrate diets increased type 2 diabetes remission rates at six months, but benefits largely diminished by 12 months.
A systematic review and meta-analysis evaluated 23 randomized trials (1,357 participants) testing low (<130 g/day or <26% energy) and very low (<10% energy) carbohydrate diets (LCDs and VLCDs) for at least 12 weeks in adults with type 2 diabetes. At six months, LCDs achieved higher rates of diabetes remission defined as HbA1c <6.5% compared to control diets (57% vs 31%; risk difference 0.32, 95% CI 0.17 to 0.47), though effect sizes were smaller and non-significant when remission was defined as HbA1c <6.5% without medication. Clinically important improvements in weight loss, triglycerides, and insulin sensitivity at six months diminished by 12 months, and data on 12-month remission were sparse. At 12 months, participants experienced clinically important but not statistically significant worsening of quality of life and LDL cholesterol.
- Study type
- Systematic review and meta-analysis of randomized clinical trials
- Who was studied
- 1,357 adults with type 2 diabetes across 23 randomized trials
- What was measured
- Diabetes remission, weight loss, HbA1c, fasting glucose, adverse events, quality of life, and lipids
THE PAPER
Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data.
Goldenberg JZ, Day A, Brinkworth GD, Sato J, Yamada S, Jönsson T, Beardsley J, Johnson JA, Thabane L, Johnston BC. BMJ, 2021.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.